Correlation Between CRISPR Therapeutics and Healthpeak Properties
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Healthpeak Properties at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Healthpeak Properties into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and Healthpeak Properties, you can compare the effects of market volatilities on CRISPR Therapeutics and Healthpeak Properties and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Healthpeak Properties. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Healthpeak Properties.
Diversification Opportunities for CRISPR Therapeutics and Healthpeak Properties
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CRISPR and Healthpeak is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Healthpeak Properties in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Healthpeak Properties and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Healthpeak Properties. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Healthpeak Properties has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Healthpeak Properties go up and down completely randomly.
Pair Corralation between CRISPR Therapeutics and Healthpeak Properties
Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 0.99 times more return on investment than Healthpeak Properties. However, CRISPR Therapeutics AG is 1.01 times less risky than Healthpeak Properties. It trades about 0.01 of its potential returns per unit of risk. Healthpeak Properties is currently generating about 0.01 per unit of risk. If you would invest 3,124 in CRISPR Therapeutics AG on October 17, 2024 and sell it today you would lose (301.00) from holding CRISPR Therapeutics AG or give up 9.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 76.49% |
| Values | Daily Returns |
CRISPR Therapeutics AG vs. Healthpeak Properties
Performance |
| Timeline |
| CRISPR Therapeutics |
| Healthpeak Properties |
CRISPR Therapeutics and Healthpeak Properties Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CRISPR Therapeutics and Healthpeak Properties
The main advantage of trading using opposite CRISPR Therapeutics and Healthpeak Properties positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Healthpeak Properties can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Healthpeak Properties will offset losses from the drop in Healthpeak Properties' long position.| CRISPR Therapeutics vs. Taiwan Semiconductor Manufacturing | CRISPR Therapeutics vs. Apple Inc | CRISPR Therapeutics vs. Alibaba Group Holding | CRISPR Therapeutics vs. Microsoft |
| Healthpeak Properties vs. NXP Semiconductors NV | Healthpeak Properties vs. Verizon Communications | Healthpeak Properties vs. Broadcom | Healthpeak Properties vs. CRISPR Therapeutics AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |